• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过自动免疫染色仪对乳腺癌常规固定细胞学标本进行激素受体状态及HER2/neu过表达检测:与组织学切片检测结果的相关性及诊断陷阱

Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls.

作者信息

Moriki Toshiaki, Takahashi Tamotsu, Ueta Shousuke, Mitani Miko, Ichien Miho

机构信息

Department of Clinical Laboratory, Kochi Medical School Hospital, Nankoku, Kochi, Japan.

出版信息

Diagn Cytopathol. 2004 Apr;30(4):251-6. doi: 10.1002/dc.20007.

DOI:10.1002/dc.20007
PMID:15048960
Abstract

Although fine-needle aspiration cytology is a routine procedure for the diagnosis of breast carcinoma, cytologic specimens have rarely been used for evaluation of hormone receptor status and HER2/neu overexpression. In order to compare the biological markers on cytology and on histology, routinely fixed smears of 110 primary breast carcinomas were immunostained for estrogen receptor (ER), progesterone receptor (PgR), and HER2/neu by automated immunostainer and the results were compared with the corresponding histologic sections. ER was expressed in 76 of 110 (69%) cases and PgR was expressed in 51 of 110 (46%). Overexpression of HER2/neu was observed in 30 of 110 (27%) cases. Concordance between cytology and histology was 98% for ER, 95% for PgR, and 100% for HER2/neu. There was no false positive result on smears. Diagnostic pitfalls in determination of hormone receptor status on smears included intratumoral heterogeneity and presence of mucin.

摘要

尽管细针穿刺细胞学检查是诊断乳腺癌的常规方法,但细胞学标本很少用于评估激素受体状态和HER2/neu过表达情况。为了比较细胞学和组织学上的生物标志物,对110例原发性乳腺癌的常规固定涂片进行雌激素受体(ER)、孕激素受体(PgR)和HER2/neu的自动免疫染色,并将结果与相应的组织学切片进行比较。110例中有76例(69%)表达ER,110例中有51例(46%)表达PgR。110例中有30例(27%)观察到HER2/neu过表达。ER细胞学与组织学的一致性为98%,PgR为95%,HER2/neu为100%。涂片无假阳性结果。涂片上激素受体状态判定的诊断陷阱包括肿瘤内异质性和黏液的存在。

相似文献

1
Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls.通过自动免疫染色仪对乳腺癌常规固定细胞学标本进行激素受体状态及HER2/neu过表达检测:与组织学切片检测结果的相关性及诊断陷阱
Diagn Cytopathol. 2004 Apr;30(4):251-6. doi: 10.1002/dc.20007.
2
Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.肿瘤组织学类型和分期而非p53、Her2-neu或组织蛋白酶D的表达是乳腺癌患者独立的预后因素。
Anticancer Res. 2004 May-Jun;24(3b):2061-8.
3
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.乳腺癌基底样亚型的临床病理意义:与激素受体及Her2/neu过表达表型的比较
Hum Pathol. 2006 Sep;37(9):1217-26. doi: 10.1016/j.humpath.2006.04.015. Epub 2006 Jul 18.
4
Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination.液基薄层细胞学制片中乳腺癌激素受体和人表皮生长因子受体 2 状态的评估:与组织切片测定的相关性。
Cancer Cytopathol. 2012 Jun 25;120(3):196-205. doi: 10.1002/cncy.20206. Epub 2012 Feb 1.
5
Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.浸润性导管乳腺癌中基底型细胞角蛋白的免疫组化鉴定——与分级、分期、雌激素受体及人表皮生长因子受体2的关系
Pol J Pathol. 2005;56(3):107-10.
6
Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?浸润性乳腺癌细针穿刺细胞学标本和组织切片中人表皮生长因子受体2蛋白及基因的检测:细胞学标本能否替代组织切片?
Oncol Rep. 2006 Apr;15(4):803-8.
7
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
8
Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.原发性乳腺癌细胞块中雌激素受体、孕激素受体和人表皮生长因子受体2的免疫化学检测
Cytopathology. 2012 Jun;23(3):181-6. doi: 10.1111/j.1365-2303.2011.00853.x. Epub 2011 Mar 6.
9
Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma.通过免疫组织化学对原发性和转移性乳腺癌患者的细针穿刺抽吸(FNA)细胞块及浆液性积液进行人表皮生长因子受体2/神经(Her2/neu)、雌激素受体和孕激素受体检测的可靠性。
Diagn Cytopathol. 2011 May;39(5):328-32. doi: 10.1002/dc.21389.
10
Prostate-specific antigen value as a marker in breast cancer.前列腺特异性抗原值作为乳腺癌的标志物
Neoplasma. 2006;53(2):161-7.

引用本文的文献

1
Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma.乳腺癌患者细针穿刺抽吸物中雌激素和孕激素受体及Her-2表达与分级的评估
J Cytol. 2018 Oct-Dec;35(4):223-228. doi: 10.4103/JOC.JOC_127_17.
2
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy.在接受内分泌治疗的乳腺癌患者的恶性胸腔积液和腹腔积液中,类固醇激素受体缺失很常见。
Oncotarget. 2017 Feb 20;8(33):55550-55561. doi: 10.18632/oncotarget.15548. eCollection 2017 Aug 15.
3
Comparison of Immunocytochemistry and Immunohistochemistry on Breast Carcinoma: A Boon or a Bane?
乳腺癌免疫细胞化学与免疫组织化学的比较:是福音还是祸根?
J Lab Physicians. 2017 Jan-Mar;9(1):5-10. doi: 10.4103/0974-2727.187915.
4
Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China.应用液基细胞学细针穿刺活检术评估中国乳腺癌患者激素受体及人表皮生长因子受体2状态的荧光原位杂交经验
Medicine (Baltimore). 2015 Jun;94(24):e981. doi: 10.1097/MD.0000000000000981.
5
Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast.乳腺癌细针穿刺物分级及激素受体免疫染色的评估
J Cytol. 2015 Jan-Mar;32(1):1-5. doi: 10.4103/0970-9371.155222.
6
Human epidermal growth factor receptor 2 and estrogen receptor status in respect to tumor characteristics in non-metastatic breast cancer.非转移性乳腺癌中人类表皮生长因子受体2和雌激素受体状态与肿瘤特征的关系
Tanaffos. 2014;13(1):26-34.
7
HER2 status in breast cancer: experience of a Spanish National Reference Centre.乳腺癌中 HER2 状态:西班牙国家参考中心的经验。
Clin Transl Oncol. 2011 May;13(5):335-40. doi: 10.1007/s12094-011-0663-4.
8
Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens.液基细胞学在乳腺癌标本激素受体分析中的应用。
Virchows Arch. 2011 Feb;458(2):153-8. doi: 10.1007/s00428-010-1025-2. Epub 2010 Dec 21.
9
HER2 gene status in primary breast cancers and matched distant metastases.原发性乳腺癌及配对远处转移灶中的HER2基因状态。
Breast Cancer Res. 2007;9(3):R31. doi: 10.1186/bcr1676.